Houston Oncology Summit: MD Anderson’s Ferran Prat, VP of industry relations, talks about partnering

Written By Mukul Verma
Mukul Verma
Previous

ImmunoGenesis Doses First Patient in Clinical Trial of Drug for Advanced Solid Tumors
Next

Cancer Focus Fund Investing $4.5 Million in ImmunoGenesis to Support Drug Trial for Relapsed or Refractory Advanced Solid Tumors